Superbugs could cause 10M extra deaths a year by 2050, experts warn
A review of antimicrobial-resistant infections requested by U.K. Prime Minister David Cameron predicts superbugs will cause at least 10 million more deaths a year by 2050 -- up from 700,000 deaths worldwide each year in 2014. The researchers warn that action is needed to stem the rise of superbugs and develop new antibiotics that are effective against such pathogens. Common treatments and procedures such as chemotherapy, caesarean sections and transplant surgeries would be dangerous or impossible without effective antibiotics. BBC
Research institute to provide $50M for HCV studies
The Patient-Centered Outcomes Research Institute said it will provide as much as $50 million for research into the best ways to diagnose and treat hepatitis C. The initiative will focus on the best screening methods, alternatives to caring for high-risk populations, analysis of trade-offs between achieving a sustained virological response and adverse events in treatments, and whether treatment should begin immediately after diagnosis or once HCV progresses to liver disease or other infections. Healio (free registration)/HCV Next
|10 ways to inspire creativity in your staff.|
Fostering creative business practices isn't as hard as it seems and can lead to smart solutions. Use these ten techniques to help inspire and encourage creativity in your staff. Read the article and learn 10 ways to get the creative juices flowing.
to learn more about Featured Content
Hunter Medical unveils elbow surgical assist device
The ElbowLOC Arm Positioning System is now available commercially, according to Hunter Medical. The device, which is used during supine and lateral decubitus elbow operations, allows for a more stable platform, gives surgeons better access and promotes faster operating time. BeckersSpine.com
|Transformational Journeys: Modern Business Planning|
Harvard Business Review explores why CFO's and their finance organizations must adapt to the changing landscape of their markets and how big data, organizational collaboration, and new cloud-based planning and analysis technologies are driving successful change.
Click here to access the report.
FDA grants orphan status to Arca's experimental Ebola drug
Arca Biopharma's rNAPc2, an investigational drug to treat viral hemorrhagic fever following Ebola virus exposure, obtained orphan drug designation from the FDA. The designation gives the drugmaker various incentives, including a market exclusivity of seven years and fee waivers. Reuters
Stakeholders weigh in on year 2 of open enrollment
At the Health Insurance Exchanges Forum March 12 and 13 in Washington, D.C., academics, consultants, health plans and state workers will bring to the table what they've learned through analysis and implementation of the exchanges. Register today.
Get LinkedIn® to AHIP Education
Join the AHIP Education LinkedIn® group to receive updates on AHIP initiatives and educational opportunities, and share thoughts and ideas with other professionals in health insurance and related fields. Nearly 5,000 members are actively contributing to this blend of information and discovery. Become a member and start a discussion.
Conference registration now open -- special pricing until Dec. 31
Registration is now open for AHIP's 2015 conferences. Plan ahead and understand the trends and issues that are critical to making health care work in 2015 and beyond. Discounted pricing is available now through Dec. 31. Browse conferences.
Product announcements appearing in SmartBrief are paid advertisements and do not reflect actual AHIP endorsements. The news reported in SmartBrief does not necessarily reflect the official position of AHIP.
Please contact one of our specialists for advertising opportunities,
editorial inquiries, job placements, or any other questions.